Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Xolair gets FDA approval for skin condition

March 24, 2014
Research and Development, Sales and Marketing FDA, Novartis, Roche, Sanofi, Xolair, chronic hives, csu

 An asthma drug developed by Roche subsidiary Genentech and Novartis has been granted an additional indication to treat chronic hives …

News
meeta_gulyani_merck_serono

Merck Serono appoints head of strategy from Roche

March 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Meeta Gulyani, Merck Serono, Roche

Merck Serono the German biopharma division of Merck has appointed Meeta Gulyani to the position of head of strategy and …

Appointment

Major new launches for 2014

March 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10

 AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …

Feature
Roche image

Roche test for HPV recommended by FDA committee

March 13, 2014
Sales and Marketing Cancer, FDA, HPV, Roche, cervical, cobas

An FDA advisory committee has recommended that a DNA test developed by Roche be approved for use as a primary …

News
Roche image

Roche makes Manchester connection

March 12, 2014
Research and Development, Sales and Marketing Manchester, NHS, Roche, ahsc, mahsc

Roche has signed a deal with a research group in the north-west of England to develop ideas which it hopes …

News
screen_shot_2014-03-07_at_13

Roche replaces chairman

March 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, franz, humar

Christoph Franz who has been on the board at Roche since 2011 has now been elected as its new chairman.  …

Appointment
roche_logo_shadow

Roche lung cancer drug fails

March 3, 2014
Research and Development, Sales and Marketing Cancer, MetMAb, NSCLC, Roche, Tarceva, avastin

An independent data monitoring committee has told Roche to halt a study of its experimental lung cancer drug MetMab due …

News
Lisa image

A treatment room view

February 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, Roche, avastin, hinsely

A little more than a year ago, Lisa Hinsley’s prospects were not good. The mother of three had been diagnosed …

Feature
roche image

Kadcyla launches in UK

February 13, 2014
Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast

 Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …

News
herceptin_roche_cancer

India court grants Herceptin injunction

February 10, 2014
Research and Development, Sales and Marketing Biocon, Herceptin, India, Mylan, Roche

Roche has been granted an injunction by a court in India to prevent generic manufacturers of its ageing breast cancer …

News
Roche image

Roche: NICE guidance ‘perverse’

February 4, 2014
Sales and Marketing NHS, NICE, NSCLC, Roche, Tarceva

Roche has poured scorn on NICE’s ‘perverse’ recommendation that its EGFR-TK inhibitor Tarceva should no longer be given to NHS …

News
Roche image

Oncology drives Roche profits

January 30, 2014
Sales and Marketing Actemra, Perjeta, Roche, Swiss, q4

Sales at Roche’s pharma division rose 7% year-on-year in 2013, driven largely by strong performances from its oncology portfolio. Group …

News
Pfizer image

Pfizer lung cancer drug suffers late-stage setback

January 28, 2014
Research and Development, Sales and Marketing Cancer, NSCLC, Pfizer, Roche, Tarceva, dacomitinib

An experimental cancer drug developed by Pfizer has failed in two separate Phase III clinical studies. Dacomitinib is a tyrosine …

News
Biocon image

Herceptin biosimilar set for Indian market

January 21, 2014
Research and Development, Sales and Marketing Biocon, Herceptin, Roche, biosimilars, canmab

Biocon has said its generic version of Roche’s ageing breast cancer drug Herceptin will go on sale in India from …

News
Roche image

Roche schizophrenia drug fails

January 21, 2014
Research and Development, Sales and Marketing Roche, biopertin, schizophrenia

Roche’s investigational schizophrenia drug bitopertin has failed to help patients with the disorder’s negative symptoms when pitted against placebo. Two …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026